ARMODAFINIL
- Product NDC
- 72189-133
- Requested package NDC
- 72189-133-30
- 11-digit product format
- 721890133
- Labeler code
- 72189
- Product ID
- 72189-133_2c28fdcb-8329-f51c-e063-6394a90a2fe2
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ARMODAFINIL
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- direct rx
- Application
- ANDA206069
- Marketing category
- ANDA
- Marketing start
- 2020-10-15
- Substance
- ARMODAFINIL
- Active strength
- 250 mg/1
- DEA schedule
- CIV
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A206069-001 | ARMODAFINIL | ARMODAFINIL | 50MG | TABLET / ORAL | AB | 2018-03-06 | |
| A206069-002 | ARMODAFINIL | ARMODAFINIL | 150MG | TABLET / ORAL | AB | 2018-03-06 | |
| A206069-003 | ARMODAFINIL | ARMODAFINIL | 250MG | TABLET / ORAL | AB | 2018-03-06 | |
| A206069-004 | ARMODAFINIL | ARMODAFINIL | 200MG | TABLET / ORAL | AB | 2018-12-07 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A206069-001 | AB |
| A206069-002 | AB |
| A206069-003 | AB |
| A206069-004 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206069-001 | ARMODAFINIL | 50MG | TABLET / ORAL | AB | 2018-03-06 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A206069-002 | ARMODAFINIL | 150MG | TABLET / ORAL | AB | 2018-03-06 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A206069-003 | ARMODAFINIL | 250MG | TABLET / ORAL | AB | 2018-03-06 | a50c72e98297… | |
| 2026-08-01 22:54:32 | 2026-06 | A206069-004 | ARMODAFINIL | 200MG | TABLET / ORAL | AB | 2018-12-07 | a50c72e98297… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-08-01 22:54:32 | 2026-06 | A206069-001 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A206069-002 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A206069-003 | AB | 1 | a50c72e98297… |
| 2026-08-01 22:54:32 | 2026-06 | A206069-004 | AB | 1 | a50c72e98297… |
openFDA label cross-check#
Cross-check layer: openFDA label JSON enriches search and identifies hydration gaps. The DailyMed Structured Product Label remains the canonical label presentation on FDA.report. Every label matching the complete exact-identifier union is deduplicated and paginated below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Armodafinil | ARMODAFINIL | Preferred Pharmaceuticals Inc. | 93b9f9a4-66d9-4ed9-8f2f-903e416e900d | 2026-03-06 | Warnings, Adverse reactions | 206069 ANDA206069 |
| Armodafinil | ARMODAFINIL | Preferred Pharmaceuticals Inc. | 4128759d-ed7c-4130-b24c-a0541f2b9e7f | 2026-03-06 | Warnings, Adverse reactions | 206069 ANDA206069 |
| Armodafinil | ARMODAFINIL | Direct_Rx | facd329b-1925-61df-e053-6294a90ab738 | 2025-01-22 | Warnings, Adverse reactions | 206069 ANDA206069 |
| ARMODAFINIL | ARMODAFINIL | direct rx | b1ba1cdd-cf57-7a8c-e053-2a95a90a2c19 | 2025-01-20 | Warnings, Adverse reactions | 206069 ANDA206069 72189-133-30 72189-133 72189013330 |
| Armodafinil | ARMODAFINIL | Bryant Ranch Prepack | cbe7c0d9-dfd2-4000-bd76-7fe3454ce64f | 2024-04-03 | Warnings, Adverse reactions | 206069 ANDA206069 |
| Armodafinil | ARMODAFINIL | Aurobindo Pharma Limited | 23da56b8-7552-4362-a1ab-e794c131194c | 2024-02-02 | Warnings, Adverse reactions | 206069 ANDA206069 |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- ARMODAFINIL
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| ARMODAFINIL | 250 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| V63XWA605I | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 724861 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| b1ba1cdd-cf57-7a8c-e053-2a95a90a2c19 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| bf31ebd7-fd9d-472c-88e1-94944f023ec0 | Product name | 3 | 20190628 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72189-133-30 | ARMODAFINIL | 30 in 1 BOTTLE | TABLET | 30 | 4 |
DailyMed Dashboard NDC Coverage#
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 724861 | armodafinil 250 MG Oral Tablet | PSN | b1ba1cdd-cf57-7a8c-e053-2a95a90a2c19 | 4 |
| 724861 | armodafinil 250 MG Oral Tablet | SCD | b1ba1cdd-cf57-7a8c-e053-2a95a90a2c19 | 4 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 72189-133-30 | 72189013330 | 30 TABLET in 1 BOTTLE (72189-133-30) | 30 tablet | 2020-10-15 | 0000-00-00 | No | No | Current |